Careers  |  Sign In  |  Register  |   Twitter

Study Identifies Preclinical Markers for High Risk of Type 1 Diabetes

A new study in The Journal of the American Medical Association built on the knowledge that type 1 diabetes often presents a “preclinical phase identified by circulating islet autoantibodies” in children. Researches determined that “progression to type 1 diabetes at 10-year follow-up after islet autoantibody seroconversion in 585 children with multiple islet autoantibodies was 69.7%.” The study concludes that future research focuses on the high-risk population of children who have multiple islet autoantibody seroconversion.

Read the study in JAMA.